Brief: Revvity Majority Of Applied Genomics Unit To Be Integrated Into Life Sciences Solutions Unit
Nov 18 (Reuters) - Revvity Inc RVTY.N :
* REVVITY: EFFECTIVE FISCAL 2025, MAJORITY OF APPLIED
GENOMICS
UNIT TO BE INTEGRATED INTO LIFE SCIENCES SOLUTIONS UNIT
* REVVITY: FROM FISCAL 2025, LIFE SCIENCES REPORTING SEGMENT
WILL
CONSIST OF LIFE SCIENCES SOLUTIONS & SOFTWARE
* REVVITY: FROM FISCAL 2025, DIAGNOSTICS REPORTING SEGMENT
WILL
CONSIST OF IMMUNODIAGNOSTICS & REPRODUCTIVE HEALTH
Source text: ID:nBw8r2SSna
Further company coverage: RVTY.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Revvity
See all newsBrief: Revvity Launches Signals Labgistics Solution To Connect And Orchestrate Scientific Workflows
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT